4
Changes in Ownership
TransMedics Group, Inc. Filed Acc 0000950170-24-013458
Chief Commercial Officer sold 736 shares at $90.09 ($66,306)
- Chief Commercial Officer acquired 736 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Khayal Tamer I · Chief Commercial Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-02-07 | Exercise or conversion : show line 1 in the form 10b5-1 | +736 | $16.00 | $11,776 | 15,111 | D |
| 2024-02-07 | Sale : show line 2 in the form 10b5-1 | −736 | $90.09 | $66,306 | 14,375 | D |
| Open-market sales · 736 sh · avg $90.09 · $66,306 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-02-07 | Exercise or conversion : show line 3 in the form 10b5-1 Stock Option (Right to Buy) | −736 | 4,970 | D |
Loading xslF345X05/ownership.xml…